LIFECORE BIOMEDICAL, INC. Financing Cash Flow
LIFECORE BIOMEDICAL, INC. (LFCR) reported Financing Cash Flow of -$1.11 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-05
- LIFECORE BIOMEDICAL, INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$852.00K.
- LIFECORE BIOMEDICAL, INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$256.00K.
- LIFECORE BIOMEDICAL, INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was -$1.39M.
- LIFECORE BIOMEDICAL, INC. net cash provided by (used in) financing activities for the quarter ending 2025-05-25 was -$402.00K.
- LIFECORE BIOMEDICAL, INC. net cash provided by (used in) financing activities for fiscal 2025 was $6.42M, a 14.45% decline from fiscal 2024.
- LIFECORE BIOMEDICAL, INC. net cash provided by (used in) financing activities for fiscal 2024 was $7.51M, a 81.09% decline from fiscal 2023.
- LIFECORE BIOMEDICAL, INC. net cash provided by (used in) financing activities for fiscal 2023 was $39.70M.
- LIFECORE BIOMEDICAL, INC. net cash provided by (used in) financing activities for fiscal 2022 was -$57.02M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 7 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$852.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$1.11M 10-Q · filed 2026-08-05 | |||
| 2026-03-31 | -$256.00K 10-Q · filed 2026-05-06 | ||||
| 2025-12-31 | -$4.43M 10-KT · filed 2026-03-16 | ||||
| 2025-09-30 | -$1.39M 10-Q · filed 2025-11-06 | ||||
| 2025-05-25 | -$402.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$7.18M 10-Q · filed 2026-08-05 | $5.33M derived: sum of 3 quarters · filed 2026-08-05 | $6.42M 10-KT · filed 2026-03-16 | |
| 2025-02-23 | -$6.78M 10-Q · filed 2026-05-06 | $5.73M derived: sum of 2 quarters · filed 2026-05-06 | $6.83M 10-Q · filed 2025-04-03 | $6.21M derived: sum of 4 quarters · filed 2026-05-06 | |
| 2024-11-24 | $12.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-01-02 | $13.61M 10-Q · filed 2025-01-02 | $12.99M derived: sum of 3 quarters · filed 2026-03-16 | $20.63M derived: sum of 4 quarters · filed 2026-03-16 | |
| 2024-08-25 | $1.09M 10-Q · filed 2025-11-06 | $479.00K derived: sum of 2 quarters · filed 2026-03-16 | $8.12M derived: sum of 3 quarters · filed 2026-03-16 | $5.67M derived: sum of 4 quarters · filed 2026-03-16 | |
| 2024-05-26 | -$614.00K derived: 10-KT 12 month − 10-Q 9 month · filed 2026-03-16 | $7.02M derived: sum of 2 quarters · filed 2026-03-16 | $4.58M derived: sum of 3 quarters · filed 2026-03-16 | $7.51M 10-KT · filed 2026-03-16 | |
| 2024-02-25 | $7.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-04-03 | $5.19M derived: sum of 2 quarters · filed 2025-04-03 | $8.12M 10-Q · filed 2025-04-03 | $32.69M derived: sum of 4 quarters · filed 2025-04-03 | |
| 2023-11-26 | -$2.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-01-02 | $486.00K 10-Q · filed 2025-01-02 | $25.06M derived: sum of 3 quarters · filed 2025-01-02 | $27.47M derived: sum of 4 quarters · filed 2025-01-02 | |
| 2023-08-27 | $2.93M 10-Q · filed 2024-10-04 | $27.50M derived: sum of 2 quarters · filed 2024-10-04 | $29.92M derived: sum of 3 quarters · filed 2024-10-04 | $38.73M derived: sum of 4 quarters · filed 2024-10-04 | |
| 2023-05-28 | $24.57M derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-26 | $26.98M derived: sum of 2 quarters · filed 2024-08-26 | $35.79M derived: sum of 3 quarters · filed 2024-08-26 | $39.70M 10-K · filed 2024-08-26 | |
| 2023-02-26 | $2.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-09 | $11.22M derived: sum of 2 quarters · filed 2024-08-09 | $15.13M 10-Q · filed 2024-08-09 | $34.27M derived: sum of 4 quarters · filed 2024-08-26 | |
| 2022-11-27 | $8.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $12.71M 10-Q · filed 2024-08-09 | $31.86M derived: sum of 3 quarters · filed 2024-08-26 | -$15.24M derived: sum of 4 quarters · filed 2024-08-26 | |
| 2022-08-28 | $3.91M 10-Q · filed 2024-08-09 | $23.05M derived: sum of 2 quarters · filed 2024-08-26 | -$24.05M derived: sum of 3 quarters · filed 2024-08-26 | -$14.17M derived: sum of 4 quarters · filed 2024-08-26 | |
| 2022-05-29 | $19.14M derived: 10-K 12 month − 10-K 9 month · filed 2024-08-26 | -$27.95M derived: sum of 2 quarters · filed 2024-08-26 | -$18.07M derived: sum of 3 quarters · filed 2024-08-26 | -$57.02M 10-K · filed 2024-08-26 | |
| 2022-02-27 | -$47.09M derived: 10-K 9 month − 10-K 6 month · filed 2024-03-20 | -$37.22M derived: sum of 2 quarters · filed 2024-03-20 | -$76.16M 10-K · filed 2024-03-20 | -$69.17M derived: sum of 4 quarters · filed 2024-03-20 | |
| 2021-11-28 | $9.88M derived: 10-K 6 month − 10-K 3 month · filed 2024-03-20 | -$29.07M 10-K · filed 2024-03-20 | -$22.08M derived: sum of 3 quarters · filed 2024-03-20 | -$10.49M derived: sum of 4 quarters · filed 2024-03-20 | |
| 2021-08-29 | -$38.95M 10-K · filed 2024-03-20 | -$31.96M derived: sum of 2 quarters · filed 2024-03-20 | -$20.37M derived: sum of 3 quarters · filed 2024-03-20 | -$25.34M derived: sum of 4 quarters · filed 2024-03-20 | |
| 2021-05-30 | $6.99M derived: 10-K 12 month − 10-K 9 month · filed 2024-03-20 | $18.58M derived: sum of 2 quarters · filed 2024-03-20 | $13.61M derived: sum of 3 quarters · filed 2024-03-20 | -$3.42M 10-K · filed 2024-03-20 | |
| 2021-02-28 | $11.59M derived: 10-K 9 month − 10-Q 6 month · filed 2024-03-20 | $6.62M derived: sum of 2 quarters · filed 2024-03-20 | -$10.41M 10-K · filed 2024-03-20 | $4.62M derived: sum of 4 quarters · filed 2024-03-20 | |
| 2020-11-29 | -$4.97M derived: 10-Q 6 month − 10-K 3 month · filed 2022-01-07 | -$22.00M 10-Q · filed 2022-01-07 | -$6.97M derived: sum of 3 quarters · filed 2024-03-20 | -$13.05M derived: sum of 4 quarters · filed 2024-03-20 | |
| 2020-08-30 | -$17.02M 10-K · filed 2024-03-20 | -$2.00M derived: sum of 2 quarters · filed 2024-03-20 | -$8.08M derived: sum of 3 quarters · filed 2024-03-20 | $6.98M derived: sum of 4 quarters · filed 2024-03-20 | |
| 2020-05-31 | $15.02M derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-16 | $8.95M derived: sum of 2 quarters · filed 2023-03-16 | $24.00M derived: sum of 3 quarters · filed 2023-03-16 | $40.02M 10-K/A · filed 2023-03-16 | |
| 2020-02-23 | -$6.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-04-08 | $8.98M derived: sum of 2 quarters · filed 2021-04-08 | $25.00M 10-Q · filed 2021-04-08 | $30.21M derived: sum of 4 quarters · filed 2021-07-29 | |
| 2019-11-24 | $15.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-01-07 | $31.07M 10-Q · filed 2021-01-07 | $36.28M derived: sum of 3 quarters · filed 2021-07-29 | $97.89M derived: sum of 4 quarters · filed 2021-07-29 | |
| 2019-08-25 | $16.02M 10-Q · filed 2020-10-07 | $21.23M derived: sum of 2 quarters · filed 2021-07-29 | $82.83M derived: sum of 3 quarters · filed 2021-07-29 | $84.32M derived: sum of 4 quarters · filed 2021-07-29 | |
| 2019-05-26 | $5.21M derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-29 | $66.82M derived: sum of 2 quarters · filed 2021-07-29 | $68.31M derived: sum of 3 quarters · filed 2021-07-29 | $79.03M 10-K · filed 2021-07-29 | |
| 2019-02-24 | $61.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-04-03 | $63.10M derived: sum of 2 quarters · filed 2020-04-03 | $73.81M 10-Q · filed 2020-04-03 | $82.42M derived: sum of 4 quarters · filed 2020-08-14 | |
| 2018-11-25 | $1.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-01-02 | $12.21M 10-Q · filed 2020-01-02 | $20.82M derived: sum of 3 quarters · filed 2020-08-14 | $21.41M derived: sum of 4 quarters · filed 2020-08-14 | |
| 2018-08-26 | $10.72M 10-Q · filed 2019-10-03 | $19.32M derived: sum of 2 quarters · filed 2020-08-14 | $19.92M derived: sum of 3 quarters · filed 2020-08-14 | $17.81M derived: sum of 4 quarters · filed 2020-08-14 | |
| 2018-05-27 | $8.61M derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-14 | $9.21M derived: sum of 2 quarters · filed 2020-08-14 | $7.09M derived: sum of 3 quarters · filed 2020-08-14 | $13.29M 10-K · filed 2020-08-14 | |
| 2018-02-25 | $600.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-04-04 | -$1.51M derived: sum of 2 quarters · filed 2019-04-04 | $4.69M 10-Q · filed 2019-04-04 | $6.81M derived: sum of 4 quarters · filed 2019-08-01 | |
| 2017-11-26 | -$2.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-01-07 | $4.09M 10-Q · filed 2019-01-07 | $6.21M derived: sum of 3 quarters · filed 2019-08-01 | $3.42M derived: sum of 4 quarters · filed 2019-08-01 | |
| 2017-08-27 | $6.20M 10-Q · filed 2018-10-05 | $8.33M derived: sum of 2 quarters · filed 2019-08-01 | $5.53M derived: sum of 3 quarters · filed 2019-08-01 | ||
| 2017-05-28 | $2.13M derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-01 | -$670.00K derived: sum of 2 quarters · filed 2019-08-01 | -$8.80M 10-K · filed 2019-08-01 | ||
| 2017-02-26 | -$2.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-04-05 | -$10.93M 10-Q · filed 2018-04-05 | |||
| 2016-11-27 | -$8.13M 10-Q · filed 2018-01-05 | ||||
| 2016-05-29 | $15.42M 10-K · filed 2018-08-09 | ||||
| 2014-02-23 | $191.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-28 | -$656.00K derived: sum of 2 quarters · filed 2014-03-28 | -$5.92M 10-Q · filed 2014-03-28 | -$7.80M derived: sum of 4 quarters · filed 2014-03-28 | |
| 2013-11-24 | -$847.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-01-03 | -$6.11M 10-Q · filed 2014-01-03 | -$8.00M derived: sum of 3 quarters · filed 2014-01-03 | -$10.91M derived: sum of 4 quarters · filed 2014-03-28 | |
| 2013-08-25 | -$5.26M 10-Q · filed 2013-09-26 | -$7.15M derived: sum of 2 quarters · filed 2013-09-26 | -$10.06M derived: sum of 3 quarters · filed 2014-03-28 | -$10.10M derived: sum of 4 quarters · filed 2014-03-28 | |
| 2013-05-26 | -$1.89M derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-07 | -$4.80M derived: sum of 2 quarters · filed 2014-03-28 | -$4.84M derived: sum of 3 quarters · filed 2014-03-28 | -$19.27M 10-K · filed 2013-08-07 | |
| 2013-02-24 | -$2.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-28 | -$2.95M derived: sum of 2 quarters · filed 2014-03-28 | -$17.38M 10-Q · filed 2014-03-28 | $21.83M derived: sum of 4 quarters · filed 2014-03-28 | |
| 2012-11-25 | -$38.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-01-03 | -$14.47M 10-Q · filed 2014-01-03 | $24.74M derived: sum of 3 quarters · filed 2014-01-03 | $25.47M derived: sum of 4 quarters · filed 2014-01-03 | |
| 2012-08-26 | -$14.43M 10-Q · filed 2013-09-26 | $24.78M derived: sum of 2 quarters · filed 2013-09-26 | $25.51M derived: sum of 3 quarters · filed 2013-09-26 | $21.21M derived: sum of 4 quarters · filed 2013-09-26 | |
| 2012-05-27 | $39.21M derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-07 | $39.94M derived: sum of 2 quarters · filed 2013-08-07 | $35.64M derived: sum of 3 quarters · filed 2013-08-07 | $35.93M 10-K · filed 2013-08-07 | |
| 2012-02-26 | $730.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-04-04 | -$3.57M derived: sum of 2 quarters · filed 2013-04-04 | -$3.27M 10-Q · filed 2013-04-04 | -$5.68M derived: sum of 4 quarters · filed 2013-08-07 | |
| 2011-11-27 | -$4.30M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2013-01-04 | -$4.00M 10-Q · filed 2013-01-04 | -$6.41M derived: sum of 3 quarters · filed 2013-08-07 | ||
| 2011-08-28 | $298.00K 10-Q/A · filed 2013-01-02 | -$2.10M derived: sum of 2 quarters · filed 2013-08-07 | |||
| 2011-05-29 | -$2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-07 | -$4.76M 10-K · filed 2013-08-07 | |||
| 2011-02-27 | -$2.36M 10-Q · filed 2012-03-28 | ||||
| 2010-11-28 | -$1.82M 10-Q · filed 2012-01-05 | ||||
| 2010-08-29 | -$159.00K 10-Q · filed 2011-10-05 | ||||
| 2010-05-30 | $19.67M 10-K · filed 2012-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |